Q BioMed Inc.
QBIO · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 45.4% | 552% | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.2% | -26.2% | -986.7% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -217.2% | -3,928.3% | -43,819.9% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -721.7% | -4,213% | -44,974% | – |
| EPS Diluted | -0.078 | -0.33 | -0.65 | -0.78 |
| % Growth | 76.3% | 49.2% | 16.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |